BPCR.L vs. FSFL.L
Compare and contrast key facts about BioPharma Credit plc (BPCR.L) and Foresight Solar Fund Ltd (FSFL.L).
Performance
BPCR.L vs. FSFL.L - Performance Comparison
Loading graphics...
BPCR.L vs. FSFL.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BPCR.L BioPharma Credit plc | 7.38% | 19.78% | 22.20% | 2.59% | 13.30% | 7.89% | 8.79% | 4.67% | 12.75% | 4.03% |
FSFL.L Foresight Solar Fund Ltd | -0.69% | -0.51% | -19.25% | -2.65% | 11.52% | 5.10% | -10.79% | 28.40% | 0.06% | 12.30% |
Different Trading Currencies
BPCR.L is traded in USD, while FSFL.L is traded in GBp. To make them comparable, the FSFL.L values have been converted to USD using the latest available exchange rates.
Fundamentals
BPCR.L:
$1.06B
FSFL.L:
£350.85M
BPCR.L:
$0.22
FSFL.L:
£0.02
BPCR.L:
4.25
FSFL.L:
31.97
BPCR.L:
0.16
FSFL.L:
4.51
BPCR.L:
4.05
FSFL.L:
12.34
BPCR.L:
0.92
FSFL.L:
0.58
BPCR.L:
$264.69M
FSFL.L:
£28.44M
BPCR.L:
$267.83M
FSFL.L:
£26.63M
BPCR.L:
$57.10M
FSFL.L:
£12.58M
Returns By Period
In the year-to-date period, BPCR.L achieves a 7.38% return, which is significantly higher than FSFL.L's -0.69% return.
BPCR.L
- 1D
- 0.86%
- 1M
- -0.21%
- YTD
- 7.38%
- 6M
- 7.15%
- 1Y
- 22.65%
- 3Y*
- 15.34%
- 5Y*
- 14.37%
- 10Y*
- —
FSFL.L
- 1D
- 2.45%
- 1M
- -3.22%
- YTD
- -0.69%
- 6M
- -14.92%
- 1Y
- -10.79%
- 3Y*
- -7.01%
- 5Y*
- -2.35%
- 10Y*
- 1.73%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BPCR.L vs. FSFL.L — Risk / Return Rank
BPCR.L
FSFL.L
BPCR.L vs. FSFL.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BioPharma Credit plc (BPCR.L) and Foresight Solar Fund Ltd (FSFL.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BPCR.L | FSFL.L | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.58 | -0.43 | +2.02 |
Sortino ratioReturn per unit of downside risk | 2.36 | -0.44 | +2.80 |
Omega ratioGain probability vs. loss probability | 1.31 | 0.94 | +0.37 |
Calmar ratioReturn relative to maximum drawdown | 2.94 | -0.35 | +3.29 |
Martin ratioReturn relative to average drawdown | 11.66 | -0.59 | +12.25 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BPCR.L | FSFL.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.58 | -0.43 | +2.02 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.14 | -0.11 | +1.25 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.09 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.95 | 0.07 | +0.88 |
Correlation
The correlation between BPCR.L and FSFL.L is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
BPCR.L vs. FSFL.L - Dividend Comparison
BPCR.L's dividend yield for the trailing twelve months is around 14.18%, more than FSFL.L's 12.88% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BPCR.L BioPharma Credit plc | 14.18% | 13.78% | 14.99% | 15.79% | 14.30% | 10.39% | 10.73% | 8.96% | 10.10% | 2.56% | 0.00% | 0.00% |
FSFL.L Foresight Solar Fund Ltd | 12.88% | 12.50% | 10.10% | 7.18% | 5.93% | 6.85% | 6.66% | 5.30% | 5.96% | 4.36% | 5.91% | 7.57% |
Drawdowns
BPCR.L vs. FSFL.L - Drawdown Comparison
The maximum BPCR.L drawdown since its inception was -14.00%, smaller than the maximum FSFL.L drawdown of -36.48%. Use the drawdown chart below to compare losses from any high point for BPCR.L and FSFL.L.
Loading graphics...
Drawdown Indicators
| BPCR.L | FSFL.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -14.00% | -35.01% | +21.01% |
Max Drawdown (1Y)Largest decline over 1 year | -7.80% | -29.91% | +22.11% |
Max Drawdown (5Y)Largest decline over 5 years | -13.92% | -35.01% | +21.09% |
Max Drawdown (10Y)Largest decline over 10 years | — | -35.01% | — |
Current DrawdownCurrent decline from peak | -0.84% | -32.09% | +31.25% |
Average DrawdownAverage peak-to-trough decline | -2.53% | -8.39% | +5.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.97% | 18.00% | -16.03% |
Volatility
BPCR.L vs. FSFL.L - Volatility Comparison
The current volatility for BioPharma Credit plc (BPCR.L) is 4.61%, while Foresight Solar Fund Ltd (FSFL.L) has a volatility of 9.49%. This indicates that BPCR.L experiences smaller price fluctuations and is considered to be less risky than FSFL.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BPCR.L | FSFL.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.61% | 9.49% | -4.88% |
Volatility (6M)Calculated over the trailing 6-month period | 9.74% | 18.62% | -8.88% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.25% | 24.76% | -10.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 12.58% | 21.00% | -8.42% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 11.89% | 20.06% | -8.17% |
Financials
BPCR.L vs. FSFL.L - Financials Comparison
This section allows you to compare key financial metrics between BioPharma Credit plc and Foresight Solar Fund Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BPCR.L vs. FSFL.L - Profitability Comparison
BPCR.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, BioPharma Credit plc reported a gross profit of 47.36M and revenue of 63.08M. Therefore, the gross margin over that period was 75.1%.
FSFL.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Foresight Solar Fund Ltd reported a gross profit of 1.92M and revenue of 1.92M. Therefore, the gross margin over that period was 100.0%.
BPCR.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, BioPharma Credit plc reported an operating income of 57.09M and revenue of 63.08M, resulting in an operating margin of 90.5%.
FSFL.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Foresight Solar Fund Ltd reported an operating income of -1.60M and revenue of 1.92M, resulting in an operating margin of -83.5%.
BPCR.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, BioPharma Credit plc reported a net income of 57.10M and revenue of 63.08M, resulting in a net margin of 90.5%.
FSFL.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Foresight Solar Fund Ltd reported a net income of -1.60M and revenue of 1.92M, resulting in a net margin of -83.5%.